Clinical treatment for persistent inflammation, immunosuppression and catabolism syndrome in patients with severe acute pancreatitis (Review)
- Authors:
- Bo Zhang
- Qigui Xiao
- Qingyong Ma
- Liang Han
-
Affiliations: Department of Hepatobiliary Surgery, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China - Published online on: September 6, 2023 https://doi.org/10.3892/etm.2023.12194
- Article Number: 495
-
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
|
Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, Tsiotos GG and Vege SS: Acute Pancreatitis Classification Working Group. Classification of acute pancreatitis-2012: Revision of the Atlanta classification and definitions by international consensus. Gut. 62:102–111. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Wilkman E, Kaukonen KM, Pettila V, Kuitunen A and Varpula M: Early hemodynamic variables and outcome in severe acute pancreatitis: A retrospective single-center cohort study. Pancreas. 42:272–278. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Hawkins RB, Raymond SL, Stortz JA, Horiguchi H, Brakenridge SC, Gardner A, Efron PA, Bihorac A, Segal M, Moore FA and Moldawer LL: Chronic critical Illness and the persistent inflammation, immunosuppression, and catabolism Syndrome. Front Immunol. 9(1511)2018.PubMed/NCBI View Article : Google Scholar | |
|
Rosenthal MD and Moore FA: Persistent inflammation, immunosuppression, and catabolism: Evolution of multiple organ dysfunction. Surg Infect (Larchmt). 17:167–172. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Osuchowski MF, Craciun F, Weixelbaumer KM, Duffy ER and Remick DG: Sepsis Chronically in MARS: Systemic cytokine responses are always mixed regardless of the outcome, magnitude, or phase of sepsis. J Immunol. 189:4648–4656. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Gentile LF, Cuenca AG, Efron PA, Ang D, Bihorac A, McKinley BA, Moldawer LL and Moore FA: Persistent inflammation and immunosuppression: A common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg. 72:1491–1501. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Rosenthal M, Gabrielli A and Moore F: The evolution of nutritional support in long term ICU patients: From multisystem organ failure to persistent inflammation immunosuppression catabolism syndrome. Minerva Anestesiol. 82:84–96. 2016.PubMed/NCBI | |
|
Mira JC, Gentile LF, Mathias BJ, Efron PA, Brakenridge SC, Mohr AM, Moore FA and Moldawer LL: Sepsis pathophysiology, chronic critical Illness, and persistent inflammation-immunosuppression and catabolism Syndrome. Crit Care Med. 45:253–262. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Shepherd JM, Cole E and Brohi K: Contemporary patterns of multiple organ dysfunction in trauma. Shock. 47:429–435. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Moore FA, Phillips SM, McClain CJ, Patel JJ and Martindale RG: Nutrition support for persistent inflammation, immunosuppression, and catabolism Syndrome. Nutr Clin Pract. 321 (1_suppl):121S–127S. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Mira JC, Brakenridge SC, Moldawer LL and Moore FA: Persistent inflammation, immunosuppression and catabolism Syndrome. Crit Care Clin. 33:245–258. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Oland GL and Hines OJ: New guidelines for the treatment of severe acute pancreatitis. Hepatobiliary Surg Nutr. 11:913–916. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Portelli M and Jones CD: Severe acute pancreatitis: Pathogenesis, diagnosis and surgical management. Hepatobiliary Pancreat Dis Int. 16:155–159. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Yang N, Li B, Ye B, Ke L, Chen F, Lu G, Jiang F, Tong Z, Li J and Li W: The long-term quality of life in patients with persistent inflammation-immunosuppression and catabolism syndrome after severe acute pancreatitis: A retrospective cohort study. J Crit Care. 42:101–106. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Koksal AR, Boga S, Alkim H, Sen I, Neijmann ST and Alkim C: Chemerin: A new biomarker to predict postendoscopic retrograde cholangiopancreatography pancreatitis. Eur J Gastroenterol Hepatol. 28:714–721. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Li J, Yang J, Huang J, Jiang DL, Zhang F, Liu MF, Qiang Y and Gu YL: Immunosuppression and the infection caused by gut mucosal barrier dysfunction in patients with early severe acute pancreatitis. Front Biosci (Landmark Ed). 18:892–900. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Glaubitz J, Wilden A, Frost F, Ameling S, Homuth G, Mazloum H, Rühlemann MC, Bang C, Aghdassi AA, Budde C, et al: Activated regulatory T-cells promote duodenal bacterial translocation into necrotic areas in severe acute pancreatitis. Gut. 72:1355–1369. 2023.PubMed/NCBI View Article : Google Scholar | |
|
Glaubitz J, Wilden A, van den Brandt C, Weiss FU, Bröker BM, Mayerle J, Lerch MM and Sendler M: Experimental pancreatitis is characterized by rapid T cell activation, Th2 differentiation that parallels disease severity, and improvement after CD4+ T cell depletion. Pancreatology. 20:1637–1647. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Joshi I, Carney WP and Rock EP: Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis. Front Immunol. 14(1130214)2023.PubMed/NCBI View Article : Google Scholar | |
|
Wen W, Zheng H, Jiang Y, Huang L, Li D, Zhang J and Zhang D: Effect of intestinal epithelial autophagy on bacterial translocation in severe acute pancreatitis. Clin Res Hepatol Gastroenterol. 41:703–710. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Liu J, Huang L, Luo M and Xia X: Bacterial translocation in acute pancreatitis. Crit Rev Microbiol. 45:539–547. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Efron PA, Mohr AM, Bihorac A, Horiguchi H, Hollen MK, Segal MS, Baker HV, Leeuwenburgh C, Moldawer LL, Moore FA and Brakenridge SC: Persistent inflammation, immunosuppression, and catabolism and the development of chronic critical illness after surgery. Surgery. 164:178–184. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Fattahi F and Ward PA: Understanding immunosuppression after sepsis. Immunity. 47:3–5. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Horiguchi H, Loftus TJ, Hawkins RB, Raymond SL, Stortz JA, Hollen MK, Weiss BP, Miller ES, Bihorac A, Larson SD, et al: Innate immunity in the persistent inflammation, immunosuppression, and catabolism Syndrome and its implications for therapy. Front Immunol. 9(595)2018.PubMed/NCBI View Article : Google Scholar | |
|
Veglia F, Perego M and Gabrilovich D: Myeloid-derived suppressor cells coming of age. Nat Immunol. 19:108–119. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Haimovich B, Zhang Z, Calvano JE, Calvano SE, Kumar A, Macor MA, Corbett S, Coyle SM and Lowry SF: Cellular metabolic regulators: Novel indicators of low-grade inflammation in humans. Ann Surg. 259:999–1006. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Eyenga P, Roussel D, Morel J, Rey B, Romestaing C, Gueguen-Chaignon V, Sheu SS and Viale JP: Time course of liver mitochondrial function and intrinsic changes in oxidative phosphorylation in a rat model of sepsis. Intensive Care Med Exp. 6(31)2018.PubMed/NCBI View Article : Google Scholar | |
|
Asehnoune K, Hotchkiss RS and Monneret G: Understanding why clinicians should care about danger-associated molecular patterns. Intensive Care Med. 42:611–614. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Zhao H, Kilgas S, Alam A, Eguchi S and Ma D: The role of extracellular adenosine triphosphate in ischemic organ injury. Crit Care Med. 44:1000–1012. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Kugelberg E: Immunometabolism: Complex metabolic responses to microbial stimuli. Nat Rev Immunol. 17:78–79. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Cheng SC, Scicluna BP, Arts RJ, Gresnigt MS, Lachmandas E, Giamarellos-Bourboulis EJ, Kox M, Manjeri GR, Wagenaars JA, Cremer OL, et al: Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis. Nat Immunol. 17:406–413. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Kau AL, Ahern PP, Griffin NW, Goodman AL and Gordon JI: Human nutrition, the gut microbiome and the immune system. Nature. 474:327–336. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Li WQ, Tong ZH, Quan ZF, Zhao RZ, Yu WK, Ye XH, Wang ZM, Wang XY, Wang ZQ, Ji DX, et al: Treatment experience of severe acute pancreatitis on 1033 cases. Zhonghua Wai Ke Za Zhi. 47:1472–1482. 2009.PubMed/NCBI(In Chinese). | |
|
Kim YJ, Kim DB, Chung WC, Lee JM, Youn GJ, Jung YD, Choi S and Oh JH: Analysis of factors influencing survival in patients with severe acute pancreatitis. Scand J Gastroenterol. 52:904–908. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Vanzant EL, Lopez CM, Ozrazgat-Baslanti T, Ungaro R, Davis R, Cuenca AG, Gentile LF, Nacionales DC, Cuenca AL, Bihorac A, et al: Persistent inflammation, immunosuppression, and catabolism syndrome after severe blunt trauma. J Trauma Acute Care Surg. 76:21–29; discussion 29-30. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Sadighi Akha AA: Aging and the immune system: An overview. J Immunol Methods. 463:21–26. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Leppaniemi A, Tolonen M, Tarasconi A, Segovia-Lohse H, Gamberini E, Kirkpatrick AW, Ball CG, Parry N, Sartelli M, Wolbrink D, et al: 2019 WSES guidelines for the management of severe acute pancreatitis. World J Emerg Surg. 14(27)2019.PubMed/NCBI View Article : Google Scholar | |
|
Lane-Fall MB, Kuza CM, Fakhry S and Kaplan LJ: The lifetime effects of injury: Postintensive care syndrome and posttraumatic stress disorder. Anesthesiol Clin. 37:135–150. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Nakamura K, Ogura K, Nakano H, Naraba H, Takahashi Y, Sonoo T, Hashimoto H and Morimura N: C-reactive protein clustering to clarify persistent inflammation, immunosuppression and catabolism syndrome. Intensive Care Med. 46:437–443. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Hu D, Ren J, Wang G, Gu G, Chen J, Zhou B, Liu S, Wu X and Li J: Persistent inflammation-immunosuppression catabolism syndrome, a common manifestation of patients with enterocutaneous fistula in intensive care unit. J Trauma Acute Care Surg. 76:725–729. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Ding RY and Ma XC: Persistent inflammatory response-immunosuppressed catabolic syndrome: A special type of chronic severe disease. Chin J Gastrointestinal Surgery. 19:734–736. 2016.(In Chinese). | |
|
Whitfield JB: Genetics and molecular biology in laboratory medicine, 1963-2013. Clin Chem Lab Med. 51:113–117. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Lai Y, Feldman KL and Clark RS: Enzyme-linked immunosorbent assays (ELISAs). Crit Care Med. 33 (12 Suppl):S433–S434. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Manohar SM, Shah P and Nair A: Flow cytometry: Principles, applications and recent advances. Bioanalysis. 13:181–198. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Xu D and Xun J: Research progress of severe acute pancreatitis with persistent inflammatory-immunosuppressive-catabolic syndrome. Chin J Practical Diagnosis and Therapy. 32:725–728. 2018.(In Chinese). | |
|
Antonini F, De Minicis S, Macarri G and Pezzilli R: . Are we ready for early discharge of patients with mild non-alcoholic acute interstitial pancreatitis? Pancreatology. 16:322–3. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Subbe CP, Kruger M, Rutherford P and Gemmel L: Validation of a modified Early Warning Score in medical admissions. QJM. 94:521–526. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Alaa AM, Yoon J, Hu S and van der Schaar M: Personalized risk scoring for critical care prognosis using mixtures of gaussian processes. IEEE Trans Biomed Eng. 65:207–218. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Kramer AA, Sebat F and Lissauer M: A review of early warning systems for prompt detection of patients at risk for clinical decline. J Trauma Acute Care Surg. 87 (1S Suppl 1):S67–S73. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Wolbrink DRJ, Kolwijck E, Ten Oever J, Horvath KD, Bouwense SAW and Schouten JA: Management of infected pancreatic necrosis in the intensive care unit: A narrative review. Clin Microbiol Infect. 26:18–25. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Karjula H, Nordblad Schmidt P, Makela J, Liisanantti JH, Ohtonen P and Saarela A: Prophylactic pancreatic duct stenting in severe acute necrotizing pancreatitis: A prospective randomized study. Endoscopy. 51:1027–1034. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Su HY, Mo ZX, Chen Z, et al: Severe immune imbalance in ICU: persistent inflammatory-immunosuppressive-catabolic syndrome. Chin Critical Care Emerg Med. 29:760–764. 2017.PubMed/NCBI View Article : Google Scholar : (In Chinese). | |
|
Wang X, Zhuang X, Wei R, Wang C, Xue X and Mao L: Protective effects of Acanthopanax vs. Ulinastatin against severe acute pancreatitis-induced brain injury in rats. Int Immunopharmacol. 24:285–298. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Pan Y, Fang H, Lu F, Pan M, Chen F, Xiong P, Yao Y and Huang H: Ulinastatin ameliorates tissue damage of severe acute pancreatitis through modulating regulatory T cells. J Inflamm (Lond). 14(7)2017.PubMed/NCBI View Article : Google Scholar | |
|
Zhu F, Yin S, Zhou L, Li Z, Yan H, Zhong Y, Wu X, Luo B, Yang L, Gan D, et al: Chinese herbal medicine xuebijing injection for acute pancreatitis: An overview of systematic reviews. Front Pharmacol. 13(883729)2022.PubMed/NCBI View Article : Google Scholar | |
|
Li C, Wang P, Zhang L, Li M, Lei X, Liu S, Feng Z, Yao Y, Chang B, Liu B and Shang H: Efficacy and safety of Xuebijing injection (a Chinese patent) for sepsis: A meta-analysis of randomized controlled trials. J Ethnopharmacol. 224:512–521. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Munir F, Jamshed MB, Shahid N, Hussain HM, Muhammad SA, Mamun AA and Zhang Q: . Advances in immunomodulatory therapy for severe acute pancreatitis. Immunol Letters. 217:72–76. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Hotchkiss RS, Monneret G and Payen D: Immunosuppression in sepsis: A novel understanding of the disorder and a new Therapeutic approach. Lancet Infect Dis. 13:260–268. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Wan J, Shan Y, Shan H, Li G, Wang T, Guan J, Liu X, Chen D, Li W and Lin Z: Thymosin-alpha1 promotes the apoptosis of regulatory T cells and survival rate in septic mice. Front Biosci (Landmark Ed). 16:3004–3013. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Hamilton JA: GM-CSF in inflammation. J Exp Med. 217(e20190945)2020.PubMed/NCBI View Article : Google Scholar | |
|
Lee KMC, Achuthan AA and Hamilton JA: GM-CSF: A promising target in inflammation and autoimmunity. Immunotargets Ther. 9:225–240. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Fu XZ and Wang Y: Interferon-gamma regulates immunosuppression in septic mice by promoting the Warburg effect through the PI3K/AKT/mTOR pathway. Mol Med. 29(95)2023.PubMed/NCBI View Article : Google Scholar | |
|
Hu Y, Xiong W, Li C and Cui Y: Continuous blood purification for severe acute pancreatitis: A systematic review and meta-analysis. Medicine (Baltimore). 98(e14873)2019.PubMed/NCBI View Article : Google Scholar | |
|
Gong D, Zhang P, Ji D, Chen Z, Li W, Li J, Li L and Liu Z: Improvement of immune dysfunction in patients with severe acute pancreatitis by high-volume hemofiltration: A preliminary report. Int J Artif Organs. 33:22–29. 2010.PubMed/NCBI | |
|
Clark E, Molnar AO, Joannes-Boyau O, Honoré PM, Sikora L and Bagshaw SM: High-volume hemofiltration for septic acute kidney injury: A systematic review and meta-analysis. Crit Care. 18(R7)2014.PubMed/NCBI View Article : Google Scholar | |
|
Almeida BM, Moreno DH, Vasconcelos V and Cacione DG: Interventions for treating catheter-related bloodstream infections in people receiving maintenance haemodialysis. Cochrane Database Syst Rev. 4(CD013554)2022.PubMed/NCBI View Article : Google Scholar | |
|
Gorski LA, Hadaway L, Hagle ME, Broadhurst D, Clare S, Kleidon T, Meyer BM, Nickel B, Rowley S, Sharpe E and Alexander M: Infusion therapy standards of practice, 8th Edition. J Infus Nurs. 44 (1S Suppl 1):S1–224. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Legrand M and Tolwani A: Anticoagulation strategies in continuous renal replacement therapy. Semin Dial. 34:416–422. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Lubbers T, Kox M, de Haan JJ, Greve JW, Pompe JC, Ramakers BP, Pickkers P and Buurman WA: Continuous administration of enteral lipid- and protein-rich nutrition limits inflammation in a human endotoxemia model. Crit Care Med. 41:1258–1265. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Plauth M, Bernal W, Dasarathy S, Merli M, Plank LD, Schütz T and Bischoff SC: ESPEN guideline on clinical nutrition in liver disease. Clin Nutr. 38:485–521. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Wang CY, Huang CT, Chen CH, Chen MF, Ching SL and Huang YC: Optimal energy delivery, rather than the implementation of a feeding protocol, may benefit clinical outcomes in critically Ill patients. Nutrients. 9(527)2017.PubMed/NCBI View Article : Google Scholar | |
|
McClave SA, Taylor BE, Martindale RG, Warren MM, Johnson DR, Braunschweig C, McCarthy MS, Davanos E, Rice TW, Cresci GA, et al: Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 40:159–211. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Bozzetti F, Arends J, Lundholm K, Micklewright A, Zurcher G and Muscaritoli M: ESPEN. ESPEN guidelines on parenteral nutrition: Non-surgical oncology. Clin Nutr. 28:445–454. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Wolfe RR: Perspective: Optimal protein intake in the elderly. J Am Med Dir Assoc. 14:65–66. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Lu C, Sharma S, McIntyre L, Rhodes A, Evans L, Almenawer S, Leduc L, Angus DC and Alhazzani W: Omega-3 supplementation in patients with sepsis: A systematic review and meta-analysis of randomized trials. Ann Intensive Care. 7(58)2017.PubMed/NCBI View Article : Google Scholar | |
|
Wang M, Veeraperumal S, Zhong S and Cheong KL: Fucoidan-Derived functional oligosaccharides: Recent developments, preparation, and potential applications. Foods. 12(878)2023.PubMed/NCBI View Article : Google Scholar | |
|
Lin J, Lv C, Wu C, Zhang H, Liu Z, Ke L, Li G, Tong Z, Tu J, et al: Incidence and risk factors of nasogastric feeding intolerance in moderately-severe to severe acute pancreatitis. BMC Gastroenterol. 22(327)2022.PubMed/NCBI View Article : Google Scholar | |
|
Sun JK, Li WQ, Ke L, Tong ZH, Ni HB, Li G, Zhang LY, Nie Y, Wang XY, et al: Early enteral nutrition prevents intra-abdominal hypertension and reduces the severity of severe acute pancreatitis compared with delayed enteral nutrition: a prospective pilot study. World J Surg. 37:2053–2060. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Heyland DK, Ortiz A, Stoppe C, Patel JJ, Yeh DD, Dukes G, Chen YJ, Almansa C and Day AG: Incidence, risk factors, and clinical consequence of enteral feeding intolerance in the mechanically ventilated critically Ill: An analysis of a multicenter, multiyear database. Crit Care Med. 49:49–59. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Gungabissoon U, Hacquoil K, Bains C, Irizarry M, Dukes G, Williamson R, Deane AM and Heyland DK: Prevalence, risk factors, clinical consequences, and treatment of enteral feed intolerance during critical illness. JPEN J Parenter Enteral Nutr. 39:441–448. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Wischmeyer PE, Puthucheary Z, San Millán I, Butz D and Grocott MPW: Muscle mass and physical recovery in ICU: Innovations for targeting of nutrition and exercise. Curr Opin Crit Care. 23:269–278. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Fuke R, Hifumi T, Kondo Y, Hatakeyama J, Takei T, Yamakawa K, Inoue S and Nishida O: Early rehabilitation to prevent postintensive care syndrome in patients with critical illness: A systematic review and meta-analysis. BMJ Open. 8(e019998)2018.PubMed/NCBI View Article : Google Scholar | |
|
Patel BK, Pohlman AS, Hall JB and Kress JP: Impact of early mobilization on glycemic control and ICU-acquired weakness in critically ill patients who are mechanically ventilated. Chest. 146:583–589. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Wang CH, Qin JM and Ben YL: Effect of early rehabilitation training on ICU acquired myasthenia in patients with mechanical ventilation. Chin Nurs Manag. 19:457–461. 2019.(In Chinese). | |
|
Maffiuletti NA, Roig M, Karatzanos E and Nanas S: Neuromuscular electrical stimulation for preventing skeletal-muscle weakness and wasting in critically ill patients: A systematic review. BMC Med. 11(137)2013.PubMed/NCBI View Article : Google Scholar | |
|
Dirks ML, Hansen D, Van Assche A, Dendale P and Van Loon LJ: Neuromuscular electrical stimulation prevents muscle wasting in critically ill comatose patients. Clin Sci (Lond). 128:357–365. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Yang YJ, Liu GY, Li RY and Liu H: Research progress of inspiratory muscle training in ICU patients with mechanical ventilation. Chin Nurs Manag. 20:1436–1440. 2020.(In Chinese). | |
|
Page VJ and McAuley DF: Sedation/drugs used in intensive care sedation. Curr Opin Anaesthesiol. 28:139–144. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Tenner S, Baillie J, DeWitt J and Vege SS: American College of Gastroenterology. American College of Gastroenterology guideline: Management of acute pancreatitis. Am J Gastroenterol. 108:1400–1415, 1416. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Working Group IAP/APA Acute Pancreatitis Guidelines. IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology. 13 (4 Suppl 2):e1–e15. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Zhu Y, Cui Y, Zhang YC, Miao HJ, Wang F, Chen RX and Rong QF: Efficacy of continuous blood purification in treatment of severe acute pancreatitis in children. Zhonghua Er Ke Za Zhi. 55:338–342. 2017.PubMed/NCBI View Article : Google Scholar : (In Chinese). | |
|
Crockett SD, Wani S, Gardner TB, Falck-Ytter Y and Barkun AN: American Gastroenterological Association Institute Clinical Guidelines Committee. American gastroenterological association institute guideline on initial management of acute pancreatitis. Gastroenterology. 154:1096–1101. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Mouncey PR, Osborn TM, Power GS, Harrison DA, Sadique MZ, Grieve RD, Jahan R, Harvey SE, Bell D, Bion JF, et al: Trial of early, goal-directed resuscitation for septic shock. N Engl J Med. 372:1301–1311. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Cooper ES and Silverstein DC: Fluid therapy and the microcirculation in health and critical Illness. Front Vet Sci. 8(625708)2021.PubMed/NCBI View Article : Google Scholar | |
|
Kara A, Akin S and Ince C: Monitoring microcirculation in critical illness. Curr Opin Crit Care. 22:444–452. 2016.PubMed/NCBI View Article : Google Scholar | |
|
De-Madaria E, Herrera-Marante I, Gonzalez-Camacho V, Bonjoch L, Quesada-Vázquez N, Almenta-Saavedra I, Miralles-Maciá C, Acevedo-Piedra NG, Roger-Ibáñez M, Sánchez-Marin C, et al: Fluid resuscitation with lactated Ringer's solution vs. normal saline in acute pancreatitis: A triple-blind, randomized, controlled trial. United European Gastroenterol J. 6:63–72. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Cordemans C, De Laet I, Van Regenmortel N, Schoonheydt K, Dits H, Huber W and Malbrain ML: Fluid management in critically ill patients: The role of extravascular lung water, abdominal hypertension, capillary leak, and fluid balance. Ann Intensive Care. 2 (Suppl 1 Diagnosis and management of intra-abdominal hyperten)(S1)2012.PubMed/NCBI View Article : Google Scholar |
